HOME >> BIOLOGY >> NEWS
Clot-busting drugs don't benefit older heart attack patients

Contrary to general belief among doctors, clot-busting drugs-- the main emergency treatment for heart attack victims --fail to benefit patients more than 75 years old and may actually increase their risk of death, according to results of a Johns Hopkins-led study.

Older heart attack patients who received intravenous thrombolytics, medications that dissolve clots in the blood vessels supplying the heart, were nearly 40 percent more likely to die within 30 days of treatment than their counterparts not given the medications, according to the study. Results are published in the May 16 issue of Circulation, an American Heart Association journal.

"There has been a widespread belief that clot-busting drugs help older patients just as they do younger ones, but the evidence always has been equivocal and the question had never been directly tested until now," says David R. Thiemann, M.D., lead author of the study and assistant professor of medicine at Hopkins. "We found that in actual clinical practice the effectiveness of these drugs varies markedly with age. Younger patients clearly benefit from thrombolytics, but the one-third of heart attack patients who are older than 75 are unlikely to have any benefit and may be at higher risk of death. More studies on how to treat the older population are urgently needed."

The study used data from the Cooperative Cardiovascular Project (conducted by the Health Care Financing Administration) on 7,864 Medicare patients aged 65 to 86, who arrived at hospitals with an acute heart attack and who were candidates for clot-dissolving therapy. There were 5,191 patients aged 65 to 75 and 2,673 patients aged 76 to 86.

Patients aged 65 to 75 who received thrombolytic therapy had a 30-day death rate of 6.8 percent, compared with 9.8 percent for patients who did not get the medications. Among patients aged 76 to 86 years, the pattern was reversed: The death rate for patients treated with thrombolytics was 18 perce
'"/>

Contact: Karen Infeld
kinfeld@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
15-May-2000


Page: 1 2

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. New and better drugs for tuberculosis goal of UH professor
3. New technique helps scientists reveal interactions between genes and drugs
4. New database to help develop AIDS drugs
5. Orange, tangerine peels could be better than drugs for lowering cholesterol
6. New papillomavirus target could lead to specific antiviral drugs for precancerous cervical lesions
7. Newer drugs more effective at curing strep throat than penicillin
8. New software developed at Rensselaer predicts promising ingredients for new drugs
9. Protein abundant in human tumors confers resistance to anticancer drugs
10. Findings could aid efforts to harness nature for making drugs
11. New way to lock DNA-slicing enzyme onto chromosomes could lead to novel anti-cancer drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/6/2019)... ... 2019 , ... VetStem Biopharma has long been ... experience. In November it spun out a human regenerative medicine subsidiary, ... of the first cGMP cell manufacturing facilities in California , VetStem signed ...
(Date:8/6/2019)... ... August 05, 2019 , ... ... announce its attendance at the Microscopy & Microanalysis 2019 Meeting ( M&M 2019 ... Oregon Convention Center. , The Microscopy & Microanalysis Meeting, organized by the Microscopy ...
(Date:8/4/2019)... ... August 02, 2019 , ... Stay on top of current hot topics ... industries. Access to all webinars is free, so be sure to register today to ... Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL OPERATIONS , August ...
Breaking Biology News(10 mins):
(Date:8/23/2019)... ... August 22, 2019 , ... An upcoming ... is scheduled to broadcast 4Q/2019. Check your local listings for more information. , ... generic drug delivery. Focusing on therapeutics for children and the elderly, viewers will ...
(Date:8/14/2019)... COLLEGE, Pa. (PRWEB) , ... August 13, 2019 ... ... in nuclear receptor and in vitro toxicology testing solutions, announced the appointment of ... healthcare industry experience to the Board. , Mark McLoughlin will lend his healthcare ...
(Date:8/8/2019)... ... August 08, 2019 , ... ... for sales and service organizations, today announced that the company’s Studio Intelligent ... for the IVA market . Inference will officially accept the award at Frost ...
(Date:8/6/2019)... DIEGO (PRWEB) , ... August 06, 2019 , ... ... Marketing Radio (LSMR) have joined forces in launching the biweekly SDBN BUZZ podcast ... further growth. SDBN BUZZ podcast will also serve to promote the region and ...
Breaking Biology Technology:
Cached News: